State of Wyoming’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

State of Wyoming’s Portfolio NGM Stock Details NGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-25	Closed	–	–	2036
2022 Q2	$0	Sell	25 -219	-90%	-$3.03K	﹤0.01%	2207
2022 Q1	$4K	Sell	244 -4,485	-95%	-$70K	﹤0.01%	1678
2021 Q4	$84K	Buy	4,729 +4,167	+741%	+$80K	0.04%	767
2021 Q3	$12K	Sell	562 -305	-35%	-$6.71K	0.01%	1011
2021 Q2	$17K	Buy	867 +863	+21,575%	+$20.2K	0.01%	958
2021 Q1	$0	Buy	+4	New	+$112	﹤0.01%	559

Other funds holding NGM

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return

PIM

Ponoi II Management San Francisco, California $38.3M AUM 32.02% 1-Year Est. Return

Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

State of Wyoming's NGM Position: Q3 2022 in Review

State of Wyoming sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q3 2022, closing a stake of 25 shares.

State of Wyoming first reported a position in NGM in Q1 2021 and held it in 6 quarters. The position peaked at $84K in Q4 2021. 128 funds tracked by Wall St. Rank hold NGM as of Q3 2022.

State of Wyoming reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
State of Wyoming sold 25 NGM Biopharmaceuticals, Inc. Common Stock shares in Q3 2022.
State of Wyoming first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 6 quarters.
State of Wyoming's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $84K in Q4 2021.
128 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q3 2022.

Based on State of Wyoming's 13F filing for Q3 2022, filed 14 Nov 2022.